Do you have questions or need assistance regarding ScreenCell technology or its applications?
Contact our support team for precise answers and personalized assistance.
ScreenCell technology is specifically designed for use on solid cancers, such as breast, lung, prostate, colon and many others.
This technology is not suitable for hematological cancers, such as leukemia or lymphoma, which affect the blood or lymphatic organs without forming solid tumors.
ScreenCell technology is designed to be used stand-alone without the need for any specific additional equipment.
However, for some further analyses, you may need additional equipment such as a digital PCR or FACS for more detailed examinations or additional tests.
Are you interested in establishing a fundamental or clinical research project focused on circulating tumor cells (CTCs) or liquid biopsy ?
Share your project details with us, and we will be delighted to assist you in bringing it to fruition.
By Amira Mehtar, Janine Wechsler, Christophe Desterke, Julien Giron-Michel, Amira Bouzidi, Aude Burlion, Fawzia Louache, Samira Kahia-Tani , Georges Uzan, and Sina Naserian
